Literature DB >> 23650317

Treated disease prevalence and spending per treated case drove most of the growth in health care spending in 1987-2009.

Kenneth E Thorpe1.   

Abstract

Analysis of data from the National Medical Expenditure Survey and the Medical Expenditure Panel Surveys from 1987-2009 reinforces previous observations that increased prevalence of treated disease has become the main driver of increased spending on health care in the United States. Higher treated disease prevalence and higher spending per treated case were associated with 50.8 percent and 39.0 percent, respectively, of the spending increase seen in the population ages eighteen and older, while their joint effect accounts for the remaining 10.2 percent. The proportion of increased spending attributable to increased treated prevalence alone is particularly high in the Medicare population: 77.7 percent, compared to 33.5 percent among the privately insured. Moreover, the current findings reveal a substantial contribution to the increase in total spending (10.4 percent) from a doubling of the share of the population considered to be obese and from increases in treatment intensity, a component of spending per treated case (11.9 percent), in 1987-2009. Constraining the cost of health care will require policy options focused on reducing the incidence of disease, as well as improved understanding of the extent to which more aggressive treatments for chronic conditions do, or do not, result in lower morbidity and mortality.

Entities:  

Keywords:  Chronic Care; Cost Of Health Care; Health Spending

Mesh:

Year:  2013        PMID: 23650317     DOI: 10.1377/hlthaff.2012.0391

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  14 in total

1.  Functional Impairment: An Unmeasured Marker of Medicare Costs for Postacute Care of Older Adults.

Authors:  S Ryan Greysen; Irena Stijacic Cenzer; W John Boscardin; Kenneth E Covinsky
Journal:  J Am Geriatr Soc       Date:  2017-06-21       Impact factor: 5.562

Review 2.  The Effect of Obesity and Chronic Conditions on Medicare Spending, 1987-2011.

Authors:  Lindsay Allen; Ken Thorpe; Peter Joski
Journal:  Pharmacoeconomics       Date:  2015-07       Impact factor: 4.981

3.  Explaining The Slowdown In Medical Spending Growth Among The Elderly, 1999-2012.

Authors:  David M Cutler; Kaushik Ghosh; Kassandra L Messer; Trivellore E Raghunathan; Susan T Stewart; Allison B Rosen
Journal:  Health Aff (Millwood)       Date:  2019-02       Impact factor: 6.301

4.  Decomposing changes in the growth of U.S. prescription drug use and expenditures, 1999-2016.

Authors:  Thomas M Selden; Salam Abdus; G Edward Miller
Journal:  Health Serv Res       Date:  2019-05-09       Impact factor: 3.402

5.  Are Two Heads Better Than One or Do Too Many Cooks Spoil the Broth? The Trade-Off between Physician Division of Labor and Patient Continuity of Care for Older Adults with Complex Chronic Conditions.

Authors:  Kenton J Johnston; Jason M Hockenberry
Journal:  Health Serv Res       Date:  2016-12       Impact factor: 3.402

6.  How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts.

Authors:  Simon Wieser; Marco Riguzzi; Mark Pletscher; Carola A Huber; Harry Telser; Matthias Schwenkglenks
Journal:  Eur J Health Econ       Date:  2018-02-22

7.  One-year effects of a group-based lifestyle intervention in adults with type 2 diabetes: A randomized encouragement trial.

Authors:  David T Liss; Emily A Finch; Andrew Cooper; Avani Sheth; Ashantí D Tejuosho; Nicola Lancki; Ronald T Ackermann
Journal:  Diabetes Res Clin Pract       Date:  2018-03-27       Impact factor: 5.602

8.  Factors Contributing to the Rising National Cost of Glucose-Lowering Medicines for Diabetes During 2005-2007 and 2015-2017.

Authors:  Xilin Zhou; Sundar S Shrestha; Hui Shao; Ping Zhang
Journal:  Diabetes Care       Date:  2020-07-31       Impact factor: 19.112

Review 9.  Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance.

Authors:  Mona S Ottum; Anahita M Mistry
Journal:  J Clin Biochem Nutr       Date:  2015-07-01       Impact factor: 3.114

10.  Explaining the Growth in US Health Care Spending Using State-Level Variation in Income, Insurance, and Provider Market Dynamics.

Authors:  Bradley Herring; Erin Trish
Journal:  Inquiry       Date:  2015-12-09       Impact factor: 1.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.